Association of Helicobacter Pylori with Gastric Pathologies in a Tertiary Care Hospital, Quetta
DOI:
https://doi.org/10.51253/pafmj.v76i6.12870Keywords:
Adenocarcinoma, Gastric Cancer, Gastritis, Helicobacter PyloriAbstract
Objective: To determine the prevalence of H. pylori infection and its relationship with histopathological changes.
Study design: Retrospective observational study.
Placer and Duration of Study: This study was conducted at Combined Military Hospital, Quetta, from 01 Jan 2022 to 30 Sep 2024.
Patients and Methods: A sample of 150 patients was selected based on a 99% confidence interval and a 5% margin of error. Adult patients (≥18 years) with complete clinical, endoscopic, and histopathological data were included. Data were analyzed using SPSS version 26, with chi-square tests applied to assess associations. Statistical significance was set at p<0.05.
Results: A total of 150 patients were included in the study, with 44 (29.3%) cases testing positive for H. pylori. The majority of cases were diagnosed with inflammatory conditions (90.7%, n=136) with Chronic non-specific gastritis being most common. Malignant tumors were observed in 8.0% (n=12) patients, with adenocarcinoma in 9 cases. There was a significant correlation between H. pylori infection and gastric adenocarcinoma (p=0.001), moderate-to-severe inflammation (p<0.001), gastric atrophy (p=0.011), and intestinal metaplasia (p=0.001). No significant associations were found between H. pylori infection and age groups (p=0.298), or gender (p=0.637).
Conclusion: Our study revealed a significant association between H. pylori infection and gastric adenocarcinoma, severity of inflammation, gastric atrophy and intestinal metaplasia however, there was no association between H. Pylori with age and gender. These findings highlight the critical role of H. pylori in gastric pathophysiology and emphasize the importance of H. pylori testing in patients with chronic gastritis and precancerous lesions.
Downloads
References
1. Feyisa ZT, Woldeamanuel BT. Prevalence and associated risk factors of gastritis among patients visiting Saint Paul Hospital Millennium Medical College, Addis Ababa, Ethiopia. PLoS One 2021; 16(2): e0246619.
https://doi.org/10.1371/journal.pone.0246619
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3): 209-249.
https://doi.org/10.3322/caac.21660
3. Huang H, Rong Y, Wang M, Guo Z, Yu Y, Long Z, et al. Analysis of gastroscopy results among healthy people undergoing a medical checkup: a retrospective study. BMC Gastroenterol 2020; 20(1): 412.
https://doi.org/10.1186/s12876-020-01557-9
4. Idrees R, Fatima S, Abdul-Ghafar J, Raheem A, Ahmad Z. Cancer prevalence in Pakistan: meta-analysis of various published studies to determine variation in cancer figures resulting from marked population heterogeneity in different parts of the country. World J Surg Oncol 2018; 16(1): 129.
https://doi.org/10.1186/s12957-018-1429-z
5. Cavatorta O, Scida S, Miraglia C, Barchi A, Nouvenne A, Leandro G, et al. Epidemiology of gastric cancer and risk factors. Acta Biomed 2018; 89(8-S): 82-87.
https://doi.org/10.23750/abm.v89i8-S.7966
6. Wong MCS, Huang J, Chan PSF, Choi P, Lao XQ, Chan SM, et al. Global incidence and mortality of gastric cancer, 1980-2018. JAMA Netw Open 2021; 4(7): e2118457.
https://doi.org/10.1001/jamanetworkopen.2021.18457
7. Mommersteeg MC, Nieuwenburg SAV, den Hollander WJ, Holster L, den Hoed CM, Capelle LG, et al. Accuracy of upper endoscopies with random biopsies to identify patients with gastric premalignant lesions who can safely be exempt from surveillance. Gastric Cancer 2021; 24(3): 680-690. https://doi.org/10.1007/s10120-020-01149-2
8. Sun F, Sun H, Mo X, Tang J, Liao Y, Wang S, et al. Increased survival rates in gastric cancer, with a narrowing gender gap and widening socioeconomic status gap: a period analysis from 1984 to 2013. J Gastroenterol Hepatol 2018; 33(4): 837-846.
https://doi.org/10.1111/jgh.14024
9. Sardar M, Kumar D, Aakash F, Partab F, Kumar S, Barkha F, et al. Prevalence and etiology of Helicobacter pylori infection in dyspepsia patients: a hospital-based cross-sectional study. Ann Med Surg 2023; 85(4): 665-669.
https://doi.org/10.1097/MS9.0000000000000120
10. Zubair M, Afridi NK, Nawaid MA, Tariq H, Bajwa AA, Khan N. Histopathological analysis of gastric biopsies using updated Sydney system. Pak Armed Forces Med J 2022; 72(6): 1969-1972. https://doi.org/10.51253/pafmj.v72i6.6458
11. Xu W, Xu L, Xu C. Relationship between Helicobacter pylori infection and gastrointestinal microecology. Front Cell Infect Microbiol 2022; 12: 938608. https://doi.org/10.3389/fcimb.2022.938608
12. Kumar S, Ghoshal UC, Patel GK. Helicobacter pylori-induced inflammation: possible factors modulating the risk of gastric cancer. Pathogens 2021; 10(9): 1099.
https://doi.org/10.3390/pathogens10091099
13. Filho AM, Warnakulasuriya S. Epidemiology of oral cancer in South and South-East Asia: incidence and mortality. Oral Dis 2024; 30(8): 4847-4854. https://doi.org/10.1111/odi.14906
14. Yang WJ, Zhao HP, Yu Y, Wang JH, Guo L, Liu JY, et al. Updates on global epidemiology, risk and prognostic factors of gastric cancer. World J Gastroenterol 2023; 29(16): 2452-2468.
https://doi.org/10.3748/wjg.v29.i16.2452
15. El Khadir M, Boukhris Alaoui S, Benajah DA, Ibrahimi SA, Chbani L, El Abkari M, et al. VacA genotypes and cagA-EPIYA-C motifs of Helicobacter pylori and gastric histopathological lesions. Int J Cancer 2020; 147(11): 3206-3214. https://doi.org/10.1002/ijc.33158
16. Kalach N, Misak Z, Bontems P, Kori M, Homan M, Cabral J, et al. Systematic review and meta-analysis of histological gastric biopsy aspects according to the updated Sydney system in children. J Pediatr Gastroenterol Nutr 2022; 74(1): 13-19.
https://doi.org/10.1097/MPG.0000000000003259
17. Requena D, Ribas E, Gilman RH, Cabrera L, Cok J, Barriga-Rivera W, et al. Effects of high altitude and diet on gastric disease severity in Helicobacter pylori infection in Peru. Helicobacter 2024; 29(6): e13147. https://doi.org/10.1111/hel.13147
18. Inoue I, Yoshimura N, Iidaka T, Horii C, Muraki S, Oka H, et al. Trends in the prevalence of atrophic gastritis and Helicobacter pylori infection over 10 years in Japan: the ROAD study 2005-2015. Mol Clin Oncol 2023; 19(1): 53. https://doi.org/10.3892/mco.2023.2649
19. Durak S, Coşar AM, Fidan S. Determination of the frequency of gastric intestinal metaplasia and its association with Helicobacter pylori. Med Records 2022; 4(3): 467-472.
https://doi.org/10.37990/medr.1158426
20. Miranda AC, Caldato C, Said MN, Levy CS, Teixeira CEC, Quaresma JAS. Gender, age, endoscopic findings, urease, and Helicobacter pylori: all uncorrelated within a sample of a high gastric cancer prevalence population in the Amazon. Arq Gastroenterol 2019; 56(3): 264-269. https://doi.org/10.1590/S0004-2803.201900000-50
21. Zavros Y, Merchant JL. The immune microenvironment in gastric adenocarcinoma. Nat Rev Gastroenterol Hepatol 2022; 19(7): 451-467. https://doi.org/10.1038/s41575-022-00591-0
22. Li ML, Hong XX, Zhang WJ, Liang YZ, Cai TT, Xu YF, et al. Helicobacter pylori plays a key role in gastric adenocarcinoma induced by spasmolytic polypeptide-expressing metaplasia. World J Clin Cases 2023; 11(16): 3714-3724. https://doi.org/10.12998/wjcc.v11.i16.3714
23. Kikuchi S, Nakajima T, Kobayashi O, Yamazaki T, Kikuichi M, Mori K, et al. Effect of age on the relationship between gastric cancer and Helicobacter pylori. Jpn J Cancer Res 2000; 91(8): 774-779. https://doi.org/10.1111/j.1349-7006.2000.tb01012.x
Downloads
Published
License
Copyright (c) 2026 Muhammad Zubair, Faiqa Mubeen, Samia Nawaz Dar, Javeria Ahsan, Nabeel Khan Afridi
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
